O
55
4
MDLZ
34
-2
CHD
42
-3
HPE
44
-3
AFL
38
-3
DRI
72
12
HP
34
5
MLM
41
-4
MCK
73
4
CHRW
64
-3
XRX
41
-5
NVDA
61
-3
AMAT
64
-2
AZO
55
-3
BDX
33
-2
ADP
66
-2
CMS
65
-2
CF
56
3
AAP
38
-4
DE
49
-10
O
55
4
MDLZ
34
-2
CHD
42
-3
HPE
44
-3
AFL
38
-3
DRI
72
12
HP
34
5
MLM
41
-4
MCK
73
4
CHRW
64
-3
XRX
41
-5
NVDA
61
-3
AMAT
64
-2
AZO
55
-3
BDX
33
-2
ADP
66
-2
CMS
65
-2
CF
56
3
AAP
38
-4
DE
49
-10
Financhill
Back

Sarepta Therapeutics Vs. AbbVie Industry Stock Comparison

Sell
49

SRPT
Sarepta Therapeutics

Last Price:
$37.84
Seasonality Move:
16.74%
Buy
66

ABBV
AbbVie

Last Price:
$191.51
Seasonality Move:
0.8%
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $37.81. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
AbbVie (ABBV) is a Buy

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $191.50. The Score for ABBV is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • ABBV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $37.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $191.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight buying pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.78 Sell
Relative Strength Index (14 RSI): 38.88 Sell
Chaikin Money Flow: -2241721 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.35 - 39.73) Sell
Bollinger Bands (100): (44.55 - 105.49) Sell

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 58.52 Buy
Chaikin Money Flow: 1302653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (182.77 - 189.01) Buy
Bollinger Bands (100): (178.01 - 203.99) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.37 Sell
20-day SMA: 38.44 Sell
50-day SMA: 47.63 Sell
200-day SMA: 100.07 Sell
8-day EMA: 39.16 Sell
20-day EMA: 40.5 Sell
50-day EMA: 50.9 Sell
200-day EMA: 88.45 Sell

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 188.63 Buy
20-day SMA: 185.54 Buy
50-day SMA: 185.65 Buy
200-day SMA: 188.81 Buy
8-day EMA: 188.78 Buy
20-day EMA: 187.28 Buy
50-day EMA: 188.01 Buy
200-day EMA: 185.95 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.74 per share, an increase next quarter of $0.95 per share, a decrease this year of $3.92 per share, and an increase next year of $7.74 per share.

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $1.88 per share, an increase this year of $2.07 per share, and an increase next year of $1.72 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):